Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

10.29
+1.0110.83%
Post-market: 10.290.0050+0.05%19:59 EDT
Volume:31.25M
Turnover:319.67M
Market Cap:10.90B
PE:-10.40
High:10.55
Open:9.39
Low:9.39
Close:9.28
52wk High:12.43
52wk Low:1.95
Shares:1.06B
Float Shares:407.00M
Volume Ratio:2.43
T/O Rate:7.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9887
EPS(LYR):-0.3820
ROE:78.05%
ROA:-30.54%
PB:-10.41
PE(LYR):-26.92

Loading ...

ImmunityBio Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 21

ImmunityBio announces availability of ANKTIVA in Saudi Arabia

TIPRANKS
·
Apr 21

ImmunityBio launches ANKTIVA in Saudi Arabia, expanding Middle East presence

Reuters
·
Apr 21

Immunitybio Announces Anktiva® Is NOW Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of Mena Partnership

THOMSON REUTERS
·
Apr 21

ImmunityBio call volume above normal and directionally bullish

TIPRANKS
·
Apr 21

ImmunityBio hit with securities class action over ANKTIVA promotion claims

Reuters
·
Apr 16

Why Is ImmunityBio Stock Rallying Thursday?

Benzinga Earnings
·
Apr 10

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and ImmunityBio (IBRX)

TIPRANKS
·
Apr 10

ImmunityBio Reports Preliminary Q1 Net Product Revenue

MT Newswires Live
·
Apr 09

Immunitybio Inc - Preliminary Q1 2026 Net Product Revenue $44.2 Mln, up 168% Year-Over-Year

THOMSON REUTERS
·
Apr 09

Press Release: ImmunityBio Reports Net Product Revenue Increased Nearly 2.7 Times Year-Over-Year to Record $44 Million in Q1 2026 and $381 Million in Cash and Marketable Securities

Dow Jones
·
Apr 09

ImmunityBio Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 08

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali

Reuters
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE-Tyson Foods, Atmus Filtration, Avis Budget

Reuters
·
Apr 06

BUZZ-U.S. STOCKS ON THE MOVE-Legence, Valero Energy, Stereotaxis

Reuters
·
Apr 06

BRIEF-Immunitybio Addresses FDA Correspondence And Reaffirms Commitment To Advertising Compliance

Reuters
·
Apr 06

Immunitybio Inc - Initiates Review and Implements Enhanced Advertising Compliance Measures

THOMSON REUTERS
·
Apr 06

Immunitybio Inc - Removes Identified Podcast and Requests Removal From Third-Party Platforms

THOMSON REUTERS
·
Apr 06

Immunitybio Inc - Submits Response to FDA Opdp Regarding Promotional Issues Raised on March 13, 2026

THOMSON REUTERS
·
Apr 06

Immunitybio Inc - Implements Corrective Actions Including Executive Training and External Regulatory Counsel

THOMSON REUTERS
·
Apr 06